Sign inGet started

Brenner Erin K.

Insider CIK 1881042 · PEAR Chief Product Dev. Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PEAR Pear Therapeutics, Inc. A Award deriv2023-02-152023-02-17952,380— $0952,380SEC↗
PEAR Pear Therapeutics, Inc. S Sale2023-01-202023-01-248,690$1.13 $9.8K43,310SEC↗
PEAR Pear Therapeutics, Inc. M Exercise deriv2023-01-142023-01-1822,000— $044,667SEC↗
PEAR Pear Therapeutics, Inc. M Exercise2023-01-142023-01-1822,000— $052,000SEC↗
PEAR Pear Therapeutics, Inc. M Exercise deriv2022-12-092022-12-0915,000— $090,234SEC↗
PEAR Pear Therapeutics, Inc. M Exercise2022-12-092022-12-0915,000$1.00 $15.0K30,000SEC↗
PEAR Pear Therapeutics, Inc. M Exercise deriv2022-05-252022-05-2715,000— $0105,234SEC↗
PEAR Pear Therapeutics, Inc. M Exercise2022-05-252022-05-2715,000$1.00 $15.0K15,000SEC↗
PEAR Pear Therapeutics, Inc. A Award deriv2022-02-162022-02-1852,520— $052,520SEC↗
PEAR Pear Therapeutics, Inc. A Award deriv2022-02-162022-02-1866,667— $066,667SEC↗
PEAR Pear Therapeutics, Inc. A Award deriv2021-12-032021-12-0758,896— $058,896SEC↗
PEAR Pear Therapeutics, Inc. A Award deriv2021-12-032021-12-0721,135— $021,135SEC↗
PEAR Pear Therapeutics, Inc. A Award deriv2021-12-032021-12-07120,234— $0120,234SEC↗
PEAR Pear Therapeutics, Inc. A Award deriv2021-12-032021-12-0744,171— $044,171SEC↗
PEAR Pear Therapeutics, Inc. A Award deriv2021-12-032021-12-07100,625— $0100,625SEC↗
PEAR Pear Therapeutics, Inc. A Award deriv2021-12-032021-12-0754,926— $054,926SEC↗